ATE415973T1 - Gemeinsame gabe von tigecyclin und digoxin - Google Patents

Gemeinsame gabe von tigecyclin und digoxin

Info

Publication number
ATE415973T1
ATE415973T1 AT05851251T AT05851251T ATE415973T1 AT E415973 T1 ATE415973 T1 AT E415973T1 AT 05851251 T AT05851251 T AT 05851251T AT 05851251 T AT05851251 T AT 05851251T AT E415973 T1 ATE415973 T1 AT E415973T1
Authority
AT
Austria
Prior art keywords
tigecycline
digoxin
joint administration
administration
joint
Prior art date
Application number
AT05851251T
Other languages
English (en)
Inventor
Donald Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE415973T1 publication Critical patent/ATE415973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT05851251T 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin ATE415973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ATE415973T1 true ATE415973T1 (de) 2008-12-15

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05851251T ATE415973T1 (de) 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (de)
EP (1) EP1804807B1 (de)
JP (1) JP2008518911A (de)
KR (1) KR20070069182A (de)
CN (1) CN101039679A (de)
AT (1) ATE415973T1 (de)
AU (1) AU2005310306A1 (de)
BR (1) BRPI0517406A (de)
CA (1) CA2582089A1 (de)
CR (1) CR9073A (de)
DE (1) DE602005011468D1 (de)
EC (1) ECSP077423A (de)
IL (1) IL182681A0 (de)
MX (1) MX2007005163A (de)
NO (1) NO20071706L (de)
RU (1) RU2007112409A (de)
WO (1) WO2006060084A2 (de)
ZA (1) ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2434944T5 (es) 2005-03-14 2022-10-20 Wyeth Llc Composiciones de tigeciclina y procedimientos de preparación
PE20070072A1 (es) * 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
KR20230169457A (ko) 2017-01-27 2023-12-15 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법
RS66714B1 (sr) 2017-09-21 2025-05-30 Neurocrine Biosciences Inc Formulacija visoke doze valbenazina i sastavi, postupci i kompleti povezani sa njim
MX2020003421A (es) * 2017-10-10 2020-07-20 Neurocrine Biosciences Inc Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).

Also Published As

Publication number Publication date
NO20071706L (no) 2007-05-24
WO2006060084A2 (en) 2006-06-08
WO2006060084A3 (en) 2006-07-20
US20060094668A1 (en) 2006-05-04
KR20070069182A (ko) 2007-07-02
MX2007005163A (es) 2007-06-26
CR9073A (es) 2007-08-28
RU2007112409A (ru) 2008-12-10
EP1804807A2 (de) 2007-07-11
ECSP077423A (es) 2007-05-30
DE602005011468D1 (de) 2009-01-15
AU2005310306A1 (en) 2006-06-08
CA2582089A1 (en) 2006-06-08
BRPI0517406A (pt) 2008-10-07
EP1804807B1 (de) 2008-12-03
JP2008518911A (ja) 2008-06-05
ZA200703441B (en) 2008-09-25
IL182681A0 (en) 2007-09-20
CN101039679A (zh) 2007-09-19

Similar Documents

Publication Publication Date Title
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
ZA200703441B (en) Coadministration of tigecycline and digoxin
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
EP4114417A4 (de) Therapeutische mittel und konjugate davon
DE602004015487D1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
IT1396915B1 (it) Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
EA200602002A1 (ru) Применение спинозинов для заживления ран
GT200500266A (es) Nuevos derivados de pirimidina y su uso
WO2011106378A3 (en) Oral b12 therapy
DE60312494D1 (de) Optisch aktives pyridinderivat und medikament, das dieses enthält
ATE433459T1 (de) Desoxo-nonadepsipeptide
EA200801890A1 (ru) Средство для лечения шума в ушах
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
NO20075508L (no) Stannsoporfinpreparater og administrering
EP4213938A4 (de) Therapeutische mittel und verwendungen davon
DK1713438T3 (da) Medicinsk sæbe
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
EP4185288A4 (de) Therapeutische mittel und verwendungen davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties